Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Ruxolitinib 20, T-Cell Lymphoma / T-Cell Prolymphocyte Leukemia

Protocol-ID: 2478 V1.0 (Mini), RUXO20, T-NHL/T-PLL

Indication(s)

  • NHL, T-Cell Type, Angioimmunoblastic (JAK2 rearrangement); ICD-10 C86.5
  • NHL, T-Cell Type, Cutaneous, Unspecified (JAK2 rearrangement); ICD-10 C84.8
  • NHL, T-Cell Type, Peripheral, Unspecified (JAK2 rearrangement); ICD-10 C84.4
  • T-Cell Prolymphocyte Leukemia (JAK2 rearrangement); ICD-10 C91.6-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 11.10.2023